Scientists have not yet developed or tested an mRNA vaccine specifically for acne. Current research on acne treatments focuses on other innovative approaches, like topical therapies and gene-editing tools, but nothing involving mRNA vaccines has reached clinical trials as of early 2026.
Acne affects millions of people worldwide, often starting in the teenage years due to clogged pores, bacteria, oil buildup, and inflammation. Standard treatments include creams with benzoyl peroxide, antibiotics, or hormones, but researchers seek better options targeting root causes.
One promising advance is clascoterone, sold as Winlevi, a topical cream that blocks androgen hormones fueling acne. Approved in places like the European Union, South Korea, Mexico, and Brazil, it marks the first new class of acne drug in over 40 years.[3] Cosmo Pharmaceuticals, an Irish biotech, leads its development and even tests it for certain cancers.[3]
Another exciting development comes from Granite Bio, backed by Sanofi Ventures. They plan clinical trials in 2026 for moderate to severe acne using the world’s first topical CRISPR treatment.[6] CRISPR is a gene-editing tool that could fix faulty genes causing excess oil or inflammation right on the skin, applied like a cream.
mRNA technology, famous from COVID-19 vaccines, trains the body to fight viruses by making proteins that trigger immunity. While Pfizer tested an mRNA flu vaccine successfully in late 2025,[5] no company applies this to acne bacteria like Cutibacterium acnes. Sessions on mRNA vaccines exist for pharmacists to explain them to patients, but only for infections, not skin conditions.[4]
Experts use 3D bioprinted skin models with immune cells to study acne and test drugs without animals.[1] This could speed up future breakthroughs, though mRNA vaccines remain unmentioned.
For now, acne care relies on proven topicals and pills. Watch for Granite’s CRISPR trials, as they might change treatment soon.
Sources
https://www.drugdiscoverynews.com/weekly-rundown-genentech-partners-with-caris-life-sciences-in-1-1b-deal-16903
https://en.wikipedia.org/wiki/Sanofi
https://www.labiotech.eu/best-biotech/top-ireland-biotechs/
https://www.pharmacytimes.com/view/the-educated-patient-clearing-up-acne
https://www.contagionlive.com/clinical/vaccines
https://www.sanofiventures.com/news
https://www.bioworld.com/content/phase3-data-2025
